The Cancer Consortium

Cancer News & Information Center

Friday, October 30th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

Gilteritinib Improves Survival in AML with FLT3 Mutations

By CC Staff on December 6, 2019

Treatment with the targeted drug gilteritinib (Xospata) can improve survival compared with chemotherapy for some people with acute myeloid leukemia (AML), new results from a large clinical trial show. All participants enrolled in the trial had […]

Children with Acute Lymphoblastic Leukemia Can Skip Radiation to the Brain

By CC Staff on December 6, 2019

In children with acute lymphoblastic leukemia (ALL), radiation therapy to prevent the cancer from returning in the brain is likely unnecessary, according to a new study. Radiation can even be omitted for children at […]

Origin Cells of Glioblastoma May Have Been Identified

By CC Staff on November 25, 2019

In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type […]

Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer

By CC Staff on November 25, 2019

A targeted cancer drug already in use to treat some women with ovarian and breast cancer may also be beneficial for some people with advanced pancreatic cancer who have inherited mutations in […]

Can Some Women Treated for Endometrial Cancer Forgo Radiation after Surgery?

By CC Staff on November 25, 2019

Some women with endometrial cancer may be able to receive less intensive treatment than is commonly given to patients without increasing the risk of the disease recurring within 5 years, according to the results […]

Improving Cancer Immunotherapy: Overcoming the Problem of ‘Exhausted’ T Cells

By CC Staff on November 25, 2019

Cancer immunotherapy relies on getting T cells—the immune system’s primary killers of infected and diseased cells—to attack and kill tumor cells. But there’s an important stumbling block for immunotherapy: T cells’ ability to kill […]

Tailored Radiation to Treat Brain Metastases Reduces Impact on Cognitive Function

By CC Staff on November 23, 2019

Radiation therapy, a widely used treatment for brain metastases, can impair important brain functions like memory, processing speed, and attention span, often greatly affecting patients’ quality of life. Initial results from a large […]

Some Brain Cells May Help to Fuel Cancer Metastasis

By CC Staff on November 23, 2019

Results from a new study may explain how astrocytes, a type of brain cell, can drive the spread of cancer to the brain. In the study, researchers showed that astrocytes can activate a […]

Posts navigation

‹ Newer 1 2 3 4 5 6 7 8 9 10 11 12 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.